האיגוד הישראלי לרפואת משפחה

הבדלים בין גרסאות בדף "קוד ATC code - ATC"

מתוך ויקירפואה

(הפניה לדף t:קוד ATC code - ATC)
תגית: הפניה חדשה
 
(793 גרסאות ביניים של 2 משתמשים אינן מוצגות)
שורה 1: שורה 1:
מפתח קודי ATC
+
#הפניה [[t:קוד ATC code - ATC]]
 
 
 
 
==גישה מהירה [[#עוגןA|A]] / [[#עוגןB|B]] / [[#עוגןC|C]] / [[#עוגןD|D]] /  [[#עוגןG|G]] / [[#עוגןH|H]] /  [[#עוגןJ|J]] /  [[#עוגןL|L]] / [[#עוגןM|M]] / [[#עוגןN|N]] /  [[#עוגןP|P]] /  [[#עוגןR|R]] / [[#עוגןS|S]] /  [[#עוגןV|V]]  ==
 
 
 
* הטבלא ניתנת למיון לפי כל אחת מהעמודות
 
 
 
{|border="1" dir="ltr" cellpadding="4" class="sortable"
 
|1st level
 
|2nd level
 
|3rd level
 
|4th level
 
|5th level
 
|Contents
 
|-
 
|{{עוגן2|עוגןA}}{{כ}}A
 
|
 
|
 
|
 
|
 
|[[Alimentary tract and metabolism]]
 
|-
 
|
 
|A01
 
|
 
|
 
|
 
|[[Stomatological preparations]]
 
|-
 
|
 
|
 
|A01A
 
|
 
|
 
|[[Stomatological preparations]]
 
|-
 
|
 
|
 
|
 
|A01AA
 
|
 
|[[Caries prophylactic agents]]
 
|-
 
|
 
|
 
|
 
|
 
| A01AA01
 
| [[Sodium fluoride]]
 
|-
 
|
 
|
 
|
 
|
 
| A01AA02
 
|[[Sodium monofluorophosphate]]
 
|-
 
|
 
|
 
|
 
|
 
| A01AA03
 
|[[Olaflur]]
 
|-
 
|
 
|
 
|
 
|
 
|A01AA04
 
|[[Stannous fluoride]]
 
|-
 
|
 
|
 
|
 
|
 
| A01AA30
 
|[[Combinations]]
 
|-
 
|
 
|
 
|
 
|
 
|A01AA51
 
|[[Sodium fluoride, combinations]]
 
|-
 
|
 
|
 
|
 
|A01AB
 
|
 
|[[Anti-infectives and antiseptics for local oral treatment]]
 
|-
 
|
 
|
 
|
 
|
 
|A01AB02
 
|[[Hydrogen peroxide]]
 
|-
 
|
 
|
 
|
 
|
 
|A01AB03
 
|[[Chlorhexidine]]
 
|-
 
|
 
|
 
|
 
|
 
|A01AB04
 
|[[Amphotericin B]]
 
|-
 
|
 
|
 
|
 
|
 
|A01AB05
 
|[[Polynoxylin]]
 
|-
 
|
 
|
 
|
 
|
 
|A01AB06
 
|[[Domiphen]]
 
|-
 
|
 
|
 
|
 
|
 
|A01AB07
 
|[[Oxyquinoline]]
 
|-
 
|
 
|
 
|
 
|
 
|A01AB08
 
|[[Neomycin]]
 
|-
 
|
 
|
 
|
 
|
 
|A01AB09
 
|[[Miconazole]]
 
|-
 
|
 
|
 
|
 
|
 
|A01AB10
 
|[[Natamycin]]
 
|-
 
|
 
|
 
|
 
|
 
|A01AB11
 
| [[Various]]
 
|-
 
|
 
|
 
|
 
|
 
| A01AB12
 
|[[Hexetidine]]
 
|-
 
|
 
|
 
|
 
|
 
| A01AB13
 
|[[Tetracycline]]
 
|-
 
|
 
|
 
|
 
|
 
| A01AB14
 
| [[Benzoxonium chloride]]
 
|-
 
|
 
|
 
|
 
|
 
| A01AB15
 
| [[Tibezonium iodide]]
 
|-
 
|
 
|
 
|
 
|
 
| A01AB16
 
|[[Mepartricin]]
 
|-
 
|
 
|
 
|
 
|
 
| A01AB17
 
|[[Metronidazole]]
 
|-
 
|
 
|
 
|
 
|
 
| A01AB18
 
| [[Clotrimazole]]
 
|-
 
|
 
|
 
|
 
|
 
| A01AB19
 
| [[Sodium perborate]]
 
|-
 
|
 
|
 
|
 
|
 
| A01AB21
 
| [[Chlortetracycline]]
 
|-
 
|
 
|
 
|
 
|
 
|A01AB22
 
| [[Doxycycline]]
 
|-
 
|
 
|
 
|
 
|
 
|A01AB23
 
| [[Minocycline]]
 
|-
 
|
 
|
 
|
 
|A01AC
 
|
 
| [[Corticosteroids for local oral treatment]]
 
|-
 
|
 
|
 
|
 
|
 
|A01AC01
 
| [[Triamcinolone]]
 
|-
 
|
 
|
 
|
 
|
 
| A01AC02
 
| [[Dexamethasone]]
 
|-
 
|
 
|
 
|
 
|
 
| A01AC03
 
| [[Hydrocortisone]]
 
|-
 
|
 
|
 
|
 
|
 
| A01AC54
 
| [[Prednisolone, combinations]]
 
|-
 
|
 
|
 
|
 
| A01AD
 
|
 
|[[Other agents for local oral treatment]]
 
|-
 
|
 
|
 
|
 
|
 
| A01AD01
 
| [[Epinephrine]]
 
|-
 
|
 
|
 
|
 
|
 
| A01AD02
 
| [[Benzydamine]]
 
|-
 
|
 
|
 
|
 
|
 
| A01AD05
 
| [[Acetylsalicylic acid]]
 
|-
 
|
 
|
 
|
 
|
 
| A01AD06
 
| [[Adrenalone]]
 
|-
 
|
 
|
 
|
 
|
 
| A01AD07
 
| [[Amlexanox]]
 
|-
 
|
 
|
 
|
 
|
 
| A01AD08
 
| [[Becaplermin]]
 
|-
 
|
 
|
 
|
 
|
 
| A01AD11
 
| [[Various]]
 
|-
 
|
 
|A02
 
|
 
|
 
|
 
|[[Drugs for acid related disorders]]
 
|-
 
|
 
|
 
|A02A
 
|
 
|
 
| [[Antacids]]
 
|-
 
|
 
|
 
|
 
|A02AA
 
|
 
| [[Magnesium compounds]]
 
|-
 
|
 
|
 
|
 
|
 
| A02AA01
 
| [[Magnesium carbonate]]
 
|-
 
|
 
|
 
|
 
|
 
| A02AA02
 
| [[Magnesium oxide]]
 
|-
 
|
 
|
 
|
 
|
 
| A02AA03
 
| [[Magnesium peroxide]]
 
|-
 
|
 
|
 
|
 
|
 
| A02AA04
 
| [[Magnesium hydroxide]]
 
|-
 
|
 
|
 
|
 
|
 
| A02AA05
 
| [[Magnesium silicate]]
 
|-
 
|
 
|
 
|
 
|
 
| A02AA10
 
| [[Combinations]]
 
|-
 
|
 
|
 
|
 
|A02AB
 
|
 
| [[Aluminium compounds]]
 
|-
 
|
 
|
 
|
 
|
 
| A02AB01
 
| [[Aluminium hydroxide]]
 
|-
 
|
 
|
 
|
 
|
 
| A02AB02
 
| [[Algeldrate]]
 
|-
 
|
 
|
 
|
 
|
 
| A02AB03
 
| [[Aluminium phosphate]]
 
|-
 
|
 
|
 
|
 
|
 
| A02AB04
 
| [[Dihydroxialumini sodium carbonate]]
 
|-
 
|
 
|
 
|
 
|
 
| A02AB05
 
| [[Aluminium acetoacetate]]
 
|-
 
|
 
|
 
|
 
|
 
| A02AB06
 
| [[Aloglutamol]]
 
|-
 
|
 
|
 
|
 
|
 
| A02AB07
 
| [[Aluminium glycinate]]
 
|-
 
|
 
|
 
|
 
|
 
| A02AB10
 
| [[Combinations]]
 
|-
 
|
 
|
 
|
 
|A02AC
 
|
 
|[[Calcium compounds]]
 
|-
 
|
 
|
 
|
 
|
 
| A02AC01
 
| [[Calcium carbonate]]
 
|-
 
|
 
|
 
|
 
|
 
|A02AC02
 
| [[Calcium silicate]]
 
|-
 
|
 
|
 
|
 
|
 
| A02AC10
 
| [[Combinations]]
 
|-
 
|
 
|
 
|
 
|A02AD
 
|
 
| [[Combinations and complexes of aluminium, calcium and magnesium compounds]]
 
|-
 
|
 
|
 
|
 
|
 
|A02AD01
 
| [[Ordinary salt combinations]]
 
|-
 
|
 
|
 
|
 
|
 
| A02AD02
 
| [[Magaldrate]]
 
|-
 
|
 
|
 
|
 
|
 
| A02AD03
 
| [[Almagate]]
 
|-
 
|
 
|
 
|
 
|
 
| A02AD04
 
| [[Hydrotalcite]]
 
|-
 
|
 
|
 
|
 
|
 
| A02AD05
 
| [[Almasilate]]
 
|-
 
|
 
|
 
|
 
|A02AF
 
|
 
| [[Antacids with antiflatulents]]
 
|-
 
|
 
|
 
|
 
|
 
| A02AF01
 
| [[Magaldrate and antiflatulents]]
 
|-
 
|
 
|
 
|
 
|
 
| A02AF02
 
| [[Ordinary salt combinations and antiflatulents]]
 
|-
 
|
 
|
 
|
 
| A02AG
 
|
 
| [[Antacids with antispasmodics]]
 
|-
 
|
 
|
 
|
 
|
 
A02AH
 
|
 
| [[Antacids with sodium bicarbonate]]
 
|-
 
|
 
|
 
|
 
|A02AX
 
|
 
| [[Antacids, other combinations]]
 
|-
 
|
 
|
 
|A02B
 
|
 
|
 
| [[Drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)]]
 
|-
 
|
 
|
 
|
 
|A02BA
 
|
 
| [[H2-receptor antagonists]]
 
|-
 
|
 
|
 
|
 
|
 
|A02BA01
 
| [[Cimetidine]]
 
|-
 
|
 
|
 
|
 
|
 
| A02BA02
 
| [[Ranitidine]]
 
|-
 
|
 
|
 
|
 
|
 
| A02BA03
 
| [[Famotidine]]
 
|-
 
|
 
|
 
|
 
|
 
| A02BA04
 
| [[Nizatidine]]
 
|-
 
|
 
|
 
|
 
|
 
| A02BA05
 
| [[Niperotidine]]
 
|-
 
|
 
|
 
|
 
|
 
| A02BA06
 
| [[Roxatidine]]
 
|-
 
|
 
|
 
|
 
|
 
|  A02BA07
 
| [[Ranitidine bismuth citrate]]
 
|-
 
|
 
|
 
|
 
|
 
|  A02BA08
 
| [[Lafutidine]]
 
|-
 
|
 
|
 
|
 
|
 
| A02BA51
 
| [[Cimetidine, combinations]]
 
|-
 
|
 
|
 
|
 
|
 
|  A02BA53
 
| [[Famotidine, combinations]]
 
|-
 
|
 
|
 
|
 
|A02BB
 
|
 
| [[Prostaglandins]]
 
|-
 
|
 
|
 
|
 
|
 
| A02BB01
 
| [[Misoprostol]]
 
|-
 
|
 
|
 
|
 
|
 
| A02BB02
 
| [[Enprostil]]
 
|-
 
|
 
|
 
|
 
|A02BC
 
|
 
| [[Proton pump inhibitors]]
 
|-
 
|
 
|
 
|
 
|
 
| A02BC01
 
| [[Omeprazole]]
 
|-
 
|
 
|
 
|
 
|
 
|  A02BC02
 
| [[Pantoprazole]]
 
|-
 
|
 
|
 
|
 
|
 
| A02BC03
 
| [[Lansoprazole]]
 
|-
 
|
 
|
 
|
 
|
 
| A02BC04
 
| [[Rabeprazole]]
 
|-
 
|
 
|
 
|
 
|
 
| A02BC05
 
| [[Esomeprazole]]
 
|-
 
|
 
|
 
|
 
|
 
|  A02BC06
 
| [[Dexlansoprazole]]
 
|-
 
|
 
|
 
|
 
|A02BD
 
|
 
| [[Combinations for eradication of Helicobacter pylori]]
 
|-
 
|
 
|
 
|
 
|
 
| A02BD01
 
| [[Omeprazole, amoxicillin and metronidazole]]
 
|-
 
|
 
|
 
|
 
|
 
| A02BD02
 
| [[Lansoprazole, tetracycline and metronidazole]]
 
|-
 
|
 
|
 
|
 
|
 
| A02BD03
 
| [[Lansoprazole, amoxicillin and metronidazole]]
 
|-
 
|
 
|
 
|
 
|
 
| A02BD04
 
| [[Pantoprazole, amoxicillin and clarithromycin]]
 
|-
 
|
 
|
 
|
 
|
 
| A02BD05
 
| [[Omeprazole, amoxicillin and clarithromycin]]
 
|-
 
|
 
|
 
|
 
|
 
| A02BD06
 
| [[Esomeprazole, amoxicillin and clarithromycin]]
 
|-
 
|
 
|
 
|
 
|
 
| A02BD07
 
| [[Lansoprazole, amoxicillin and clarithromycin]]
 
|-
 
|
 
|
 
|
 
|
 
| A02BD08
 
| [[Bismuth subcitrate, tetracycline and metronidazole]]
 
|-
 
|
 
|
 
|
 
|A02BX
 
|
 
| [[Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)]]
 
|-
 
|
 
|
 
|
 
|
 
|    A02BX01
 
| [[Carbenoxolone]]
 
|-
 
|
 
|
 
|
 
|
 
|    A02BX02
 
| [[Sucralfate]]
 
|-
 
|
 
|
 
|
 
|
 
|    A02BX03
 
| [[Pirenzepine]]
 
|-
 
|
 
|
 
|
 
|
 
|    A02BX04
 
| [[Methiosulfonium chloride]]
 
|-
 
|
 
|
 
|
 
|
 
|  A02BX05
 
| [[Bismuth subcitrate]]
 
|-
 
|
 
|
 
|
 
|
 
|    A02BX06
 
| [[Proglumide]]
 
|-
 
|
 
|
 
|
 
|
 
|    A02BX07
 
| [[Gefarnate]]
 
|-
 
|
 
|
 
|
 
|
 
|    A02BX08
 
| [[Sulglicotide]]
 
|-
 
|
 
|
 
|
 
|
 
|    A02BX09
 
| [[Acetoxolone]]
 
|-
 
|
 
|
 
|
 
|
 
|    A02BX10
 
| [[Zolimidine]]
 
|-
 
|
 
|
 
|
 
|
 
|    A02BX11
 
| [[Troxipide]]
 
|-
 
|
 
|
 
|
 
|
 
|    A02BX12
 
| [[Bismuth subnitrate]]
 
|-
 
|
 
|
 
|
 
|
 
|    A02BX13
 
| [[Alginic acid]]
 
|-
 
|
 
|
 
|
 
|
 
|    A02BX51
 
| [[Carbenoxolone, combinations excluding psycholeptics]]
 
|-
 
|
 
|
 
|
 
|
 
|    A02BX71
 
| [[Carbenoxolone, combinations with psycholeptics]]
 
|-
 
|
 
|
 
|
 
|
 
|    A02BX77
 
| [[Gefarnate, combinations with psycholeptics]]
 
|-
 
|
 
|
 
|A02X
 
|
 
|
 
| [[Other drugs for acid related disorders]]
 
|-
 
|
 
|A03
 
|
 
|
 
|
 
|[[Drugs for functional gastrointestinal disorders]]
 
|-
 
|
 
|A04
 
|
 
|
 
|
 
|[[Antiemetics and antinauseants]]
 
|-
 
|
 
|A05
 
|
 
|
 
|
 
|[[Bile and liver therapy]]
 
|-
 
|
 
|A06
 
|
 
|
 
|
 
|[[Drugs for constipation]]
 
|-
 
|
 
|A07
 
|
 
|
 
|
 
|[[Antidiarrheals, intestinal anti-inflammatory/anti-infective agents]]
 
|-
 
|
 
|A08
 
|
 
|
 
|
 
|[[Antiobesity preparations, excluding diet products]]
 
|-
 
|
 
|A09
 
|
 
|
 
|
 
|[[Digestives,including enzymes]]
 
|-
 
|
 
|A10
 
|
 
|
 
|
 
|[[Drugs used in diabetes]]
 
|-
 
|
 
|A11
 
|
 
|
 
|
 
|[[Vitamins]]
 
|-
 
|
 
|A12
 
|
 
|
 
|
 
|[[Mineral supplements]]
 
|-
 
|
 
|A13
 
|
 
|
 
|
 
|[[Tonics]]
 
|-
 
|
 
|A14
 
|
 
|
 
|
 
|[[Anabolic agents for systemic use]]
 
|-
 
|
 
|A15
 
|
 
|
 
|
 
|[[Appetite stimulants]]
 
|-
 
|
 
|A16
 
|
 
|
 
|
 
|[[Other alimentary tract and metabolism products]]
 
|-
 
|{{עוגן2|עוגןB}}{{כ}}B
 
|
 
|
 
|
 
|
 
|[[Blood and blood forming organs]] ‏
 
|-
 
|{{עוגן2|עוגןC}}{{כ}}C
 
|
 
|
 
|
 
|
 
|[[Cardiovascular system]] ‏
 
|-
 
|
 
|C01
 
|
 
|
 
|
 
|[[Cardiac therapy]]
 
|-
 
|
 
|C02
 
|
 
|
 
|
 
|[[Antihypertensives]]
 
|-
 
|
 
|C03
 
|
 
|
 
|
 
|[[Diuretics]]
 
|-
 
|
 
|C04
 
|
 
|
 
|
 
|[[Peripheral vasodilators]]
 
|-
 
|
 
|C05
 
|
 
|
 
|
 
|[[Vasoprotectives]]
 
|-
 
|
 
|C07
 
|
 
|
 
|
 
|[[Beta blocking agents]]
 
|-
 
|
 
|C08
 
|
 
|
 
|
 
|[[Calcium channel blockers]]
 
|-
 
|
 
|C09
 
|
 
|
 
|
 
|[[Agents acting on the renin-angiotensin system]]
 
|-
 
|
 
|C10
 
|
 
|
 
|
 
|[[Lipid modifying agents]]
 
|-
 
|
 
|
 
|C10A
 
|
 
|
 
|[[Lipid modifying agents, plain]]
 
|-
 
|
 
|
 
|C10B
 
|
 
|
 
|[[Lipid modifying agents, combinations]]
 
|-
 
|{{עוגן2|עוגןD}}{{כ}}D
 
|
 
|
 
|
 
|
 
|[[Dermatologicals]]
 
|-
 
|{{עוגן2|עוגןG}}{{כ}}G
 
|
 
|
 
|
 
|
 
|[[Genito-urinary system and sex hormones]] ‏
 
|-
 
|{{עוגן2|עוגןH}}{{כ}}H
 
|
 
|
 
|
 
|
 
|[[Systemic hormonal preparations, excluding sex hormones and insulins]] ‏
 
|-
 
|{{עוגן2|עוגןJ}}{{כ}}J
 
|
 
|
 
|
 
|
 
|[[Antiinfectives for systemic use]] ‏
 
|-
 
|
 
|J01
 
|
 
|
 
|
 
|[[Antibacterials for systemic use]]
 
|-
 
|
 
|J02
 
|
 
|
 
|
 
|[[Antimycotics for systemic use]]
 
|-
 
|
 
|J04
 
|
 
|
 
|
 
|[[Antimycobacterials]]
 
|-
 
|
 
|J05
 
|
 
|
 
|
 
|[[Antivirals for systemic use]]
 
|-
 
|
 
|
 
|J05A
 
|
 
|
 
|[[Direct acting antiviral drugs]]
 
|-
 
|
 
|
 
|
 
|J05AA
 
|
 
|[[Thiosemicarbazones]]
 
|-
 
|
 
|
 
|
 
|J05AB
 
|
 
|[[Nucleosides and nucleotides excluding reverse transcriptase inhibitors]]
 
|-
 
|
 
|
 
|
 
|J05AC
 
|
 
|[[Cyclic amines]]
 
|-
 
|
 
|
 
|
 
|J05AD
 
|
 
|[[Phosphonic acid derivatives]]
 
|-
 
|
 
|
 
|
 
|J05AE
 
|
 
|[[Protease inhibitors]]
 
|-
 
|
 
|
 
|
 
|J05AF
 
|
 
|[[Nucleoside and nucleotide reverse transcriptase inhibitors]]
 
|-
 
|
 
|
 
|
 
|
 
|J05AF01
 
| [[Zidovudine]]
 
|-
 
|
 
|
 
|
 
|
 
|J05AF02
 
| [[Didanosine]]
 
|-
 
|
 
|
 
|
 
|
 
|J05AF03
 
| [[Zalcitabine]]
 
|-
 
|
 
|
 
|
 
|
 
|J05AF04
 
| [[Stavudine]]
 
|-
 
|
 
|
 
|
 
|
 
|J05AF05
 
| [[Lamivudine]]
 
|-
 
|
 
|
 
|
 
|
 
|J05AF06
 
| [[Abacavir]]
 
|-
 
|
 
|
 
|
 
|
 
|J05AF07
 
| Tenofovir [[disoproxil]]
 
|-
 
|
 
|
 
|
 
|
 
|J05AF08
 
| Adefovir [[dipivoxil]]
 
|-
 
|
 
|
 
|
 
|
 
|J05AF09
 
| [[Emtricitabine]]
 
|-
 
|
 
|
 
|
 
|
 
|J05AF10
 
| [[Entecavir]]
 
|-
 
|
 
|
 
|
 
|
 
|J05AF11
 
| [[Telbivudine]]
 
|-
 
|
 
|
 
|
 
|
 
|J05AF12
 
| [[Clevudine]]
 
|-
 
|
 
|
 
|
 
|J05AG
 
|
 
|[[Non-nucleoside reverse transcriptase inhibitors]]
 
|-
 
|
 
|
 
|
 
|J05AH
 
|
 
|[[Neuraminidase inhibitors]]
 
|-
 
|
 
|
 
|
 
|J05AR
 
|
 
|[[Antivirals for treatment of HIV infections, combinations]]
 
|-
 
|
 
|
 
|
 
|J05AX
 
|
 
|[[Other antivirals]]
 
|-
 
|
 
|J06
 
|
 
|
 
|
 
|[[Immune sera and immunoglobulins]]
 
|-
 
|
 
|
 
|J06A
 
|
 
|
 
| [[Immune sera]]
 
|-
 
|
 
|
 
|
 
|J06AA
 
|
 
| [[Immune sera]]
 
|-
 
|
 
|
 
|
 
|
 
|J06AA01
 
| [[Diphtheria antitoxin]]
 
|-
 
|
 
|
 
|
 
|
 
| J06AA02
 
| [[Tetanus antitoxin]]
 
|-
 
|
 
|
 
|
 
|
 
|J06AA03
 
| [[Snake venom antiserum]]
 
|-
 
|
 
|
 
|
 
|
 
| J06AA04
 
| [[Botulinum antitoxin]]
 
|-
 
|
 
|
 
|
 
|
 
|J06AA05
 
| [[Gas-gangrene sera]]
 
|-
 
|
 
|
 
|
 
|
 
| J06AA06
 
| [[Rabies serum]]
 
|-
 
|
 
|
 
|J06B
 
|
 
|
 
| [[Immunoglobulins]]
 
|-
 
|
 
|
 
|
 
|J06BA
 
|
 
|[[Immunoglobulins, normal human]]
 
|-
 
|
 
|
 
|
 
|
 
|J06BA01
 
|[[Immunoglobulins, normal human, for extravascular administration]]
 
|-
 
|
 
|
 
|
 
|
 
| J06BA02
 
|[[Immunoglobulins, normal human, for intravascular administration]]
 
|-
 
|
 
|
 
|
 
|J06BB
 
|
 
|[[Specific immunoglobulins]]
 
|-
 
|
 
|
 
|
 
|
 
|J06BB01
 
|[[Anti-D (rh) immunoglobulin]]
 
|-
 
|
 
|
 
|
 
|
 
|J06BB02
 
| [[Tetanus immunoglobulin]]
 
|-
 
|
 
|
 
|
 
|
 
|J06BB03
 
| [[Varicella/zoster immunoglobulin]]
 
|-
 
|
 
|
 
|
 
|
 
|J06BB04
 
| [[Hepatitis B immunoglobulin]]
 
|-
 
|
 
|
 
|
 
|
 
|J06BB05
 
| [[Rabies immunoglobulin]]
 
|-
 
|
 
|
 
|
 
|
 
| J06BB06
 
| [[Rubella immunoglobulin]]
 
|-
 
|
 
|
 
|
 
|
 
| J06BB07
 
| [[Vaccinia immunoglobulin]]
 
|-
 
|
 
|
 
|
 
|
 
|J06BB08
 
| [[Staphylococcus immunoglobulin]]
 
|-
 
|
 
|
 
|
 
|
 
| J06BB09
 
| [[Cytomegalovirus immunoglobulin]]
 
|-
 
|
 
|
 
|
 
|
 
|J06BB10
 
| [[Diphtheria immunoglobulin]]
 
|-
 
|
 
|
 
|
 
|
 
|J06BB11
 
| [[Hepatitis A immunoglobulin]]
 
|-
 
|
 
|
 
|
 
|
 
|J06BB12
 
| [[Encephalitis, tick borne immunoglobulin]]
 
|-
 
|
 
|
 
|
 
|
 
|J06BB13
 
| [[Pertussis immunoglobulin]]
 
|-
 
|
 
|
 
|
 
|
 
|J06BB14
 
|[[Morbilli immunoglobulin]]
 
|-
 
|
 
|
 
|
 
|
 
|J06BB15
 
| [[Parotitis immunoglobulin]]
 
|-
 
|
 
|
 
|
 
|
 
|J06BB16
 
| [[Palivizumab]]
 
|-
 
|
 
|
 
|
 
|
 
| J06BB17
 
| [[Motavizumab]]
 
|-
 
|
 
|
 
|
 
|
 
|J06BB30
 
| [[Combinations]]
 
|-
 
|
 
|
 
|
 
|J06BC
 
|
 
| [[Other immunoglobulins]]
 
|-
 
|
 
|
 
|
 
|
 
|J06BC01
 
| [[Nebacumab]]
 
|-
 
|{{עוגן2|עוגןL}}{{כ}}L 
 
|
 
|
 
|
 
|
 
|[[Antineoplastic and immunomodulating agents]] ‏
 
|-
 
|{{עוגן2|עוגןM}}{{כ}}M
 
|
 
|
 
|
 
|
 
|[[Musculo-skeletal system]] ‏
 
|-
 
|
 
|M01
 
|
 
|
 
|
 
|[[Anti-inflammatory and antirheumatic products]]
 
|-
 
|
 
|
 
|M01A
 
|
 
|
 
|[[Anti-inflammatory and antirheumatic products, non-steroids]]
 
|-
 
|
 
|
 
|
 
|M01AA
 
|
 
|[[Butylpyrazolidines]]
 
|-
 
|
 
|
 
|
 
|M01AB
 
|
 
|[[Acetic acid derivatives and related substances]]
 
|-
 
|
 
|
 
|
 
|
 
| M01AB01
 
| [[Indometacin]]
 
|-
 
|
 
|
 
|
 
|
 
| M01AB02
 
| [[Sulindac]]
 
|-
 
|
 
|
 
|
 
|
 
| M01AB03
 
| [[Tolmetin]]
 
|-
 
|
 
|
 
|
 
|
 
| M01AB04
 
| [[Zomepirac]]
 
|-
 
|
 
|
 
|
 
|
 
| M01AB05
 
| [[Diclofenac]]
 
|-
 
|
 
|
 
|
 
|
 
| M01AB06
 
| [[Alclofenac]]
 
|-
 
|
 
|
 
|
 
|
 
| M01AB07
 
| [[Bumadizone]]
 
|-
 
|
 
|
 
|
 
|
 
| M01AB08
 
| [[Etodolac]]
 
|-
 
|
 
|
 
|
 
|
 
| M01AB09
 
| [[Lonazolac]]
 
|-
 
|
 
|
 
|
 
|
 
| M01AB10
 
| [[Fentiazac]]
 
|-
 
|
 
|
 
|
 
|
 
| M01AB11
 
| [[Acemetacin]]
 
|-
 
|
 
|
 
|
 
|
 
| M01AB12
 
| [[Difenpiramide]]
 
|-
 
|
 
|
 
|
 
|
 
| M01AB13
 
| [[Oxametacin]]
 
|-
 
|
 
|
 
|
 
|
 
| M01AB14
 
| [[Proglumetacin]]
 
|-
 
|
 
|
 
|
 
|
 
| M01AB15
 
| [[Ketorolac]]
 
|-
 
|
 
|
 
|
 
|
 
| M01AB16
 
| [[Aceclofenac]]
 
|-
 
|
 
|
 
|
 
|
 
| M01AB17
 
| [[Bufexamac]]
 
|-
 
|
 
|
 
|
 
|
 
| M01AB51
 
| [[Indometacin, combinations]]
 
|-
 
|
 
|
 
|
 
|
 
| M01AB55
 
| [[Diclofenac, combinations]]
 
|-
 
|
 
|
 
|
 
|M01AC
 
|
 
|[[Oxicams]]
 
|-
 
|
 
|
 
|
 
|M01AE
 
|
 
|[[Propionic acid derivatives]]
 
|-
 
|
 
|
 
|
 
|M01AG
 
|
 
|[[Fenamates]]
 
|-
 
|
 
|
 
|
 
|M01AH
 
|
 
|[[Coxibs]]
 
|-
 
|
 
|
 
|
 
|M01AX
 
|
 
|[[Other anti-inflammatory and antirheumatic agents, non-steroids]]
 
|-
 
|
 
|
 
|M01B
 
|
 
|
 
|[[Anti-inflammatory/antirheumatic agents in combination]]
 
|-
 
|
 
|
 
|M01C
 
|
 
|
 
|[[Specific antirheumatic agents]]
 
|-
 
|
 
|M02
 
|
 
|
 
|
 
|[[Topical products for joint and muscular pain]]
 
|-
 
|
 
|M03
 
|
 
|
 
|
 
|[[Muscle relaxants]]
 
|-
 
|
 
|M04
 
|
 
|
 
|
 
|[[Antigout preparations]]
 
|-
 
|
 
|M05
 
|
 
|
 
|
 
|[[Drugs for treatment of bone diseases]]
 
|-
 
|
 
|M09
 
|
 
|
 
|
 
|[[Other drugs for disorders of the musculo-skeletal system]]
 
|-
 
|{{עוגן2|עוגןN}}{{כ}}N
 
|
 
|
 
|
 
|
 
|[[Nervous system]] ‏
 
|-
 
|
 
|N01
 
|
 
|
 
|
 
| [[Anesthetics]]
 
|-
 
|
 
|N02
 
|
 
|
 
|
 
| [[Analgesics]]
 
|-
 
|
 
|N03
 
|
 
|
 
|
 
| [[Antiepileptics]]
 
|-
 
|
 
|N04
 
|
 
|
 
|
 
|[[Anti-parkinson drugs]]
 
|-
 
|
 
|N05
 
|
 
|
 
|
 
| [[Psycholeptics]]
 
|-
 
|
 
|
 
|N05A
 
|
 
|
 
| [[Antipsychotics]]
 
|-
 
|
 
|
 
|
 
|N05AA
 
|
 
|[[Phenothiazines with aliphatic side-chain]]
 
|-
 
|
 
|
 
|
 
|N05AB
 
|
 
|[[Phenothiazines with piperazine structure]]
 
|-
 
|
 
|
 
|
 
|N05AC
 
|
 
|[[Phenothiazines with piperidine structure]]
 
|-
 
|
 
|
 
|
 
|N05AD
 
|
 
|[[Butyrophenone derivatives]]
 
|-
 
|
 
|
 
|
 
|N05AE
 
|
 
|[[Indole derivatives]]
 
|-
 
|
 
|
 
|
 
|N05AF
 
|
 
|[[Thioxanthene derivative]]
 
|-
 
|
 
|
 
|
 
|N05AG
 
|
 
|[[Diphenylbutylpiperidine derivatives]]
 
|-
 
|
 
|
 
|
 
|N05AH
 
|
 
|[[Diazepines, oxazepines, thiazepines and oxepines]]
 
|-
 
|
 
|
 
|
 
|N05AL
 
|
 
|[[Benzamides]]
 
|-
 
|
 
|
 
|
 
|N05AN
 
|
 
|[[Lithium]]
 
|-
 
|
 
|
 
|
 
|N05AX
 
|
 
|[[Other antipsychotics]]
 
|-
 
|-
 
|
 
|
 
|
 
|
 
| N05AX07
 
|[[Prothipendyl]]
 
|-
 
|
 
|
 
|
 
|
 
|N05AX08
 
|[[Risperidone]]
 
|-
 
|
 
|
 
|
 
|
 
|N05AX10
 
|[[Mosapramine]]
 
|-
 
|
 
|
 
|
 
|
 
|N05AX11
 
|[[Zotepine]]
 
|-
 
|
 
|
 
|
 
|
 
|N05AX12
 
|[[Aripiprazole]]
 
|-
 
|
 
|
 
|
 
|
 
|N05AX13
 
|[[Paliperidone]]
 
|-
 
|
 
|
 
|
 
|
 
|N05AX14
 
|[[Iloperidone]]
 
|-
 
|
 
|
 
|N05B
 
|
 
|
 
| [[Anxiolytics]]
 
|-
 
|
 
|
 
|N05C
 
|
 
|
 
| [[Hypnotics and sedatives]]
 
|-
 
|
 
|N06
 
|
 
|
 
|
 
| [[Psychoanaleptics]]
 
|-
 
|
 
|N07
 
|
 
|
 
|
 
| [[Other nervous system drugs]]
 
|-
 
|{{עוגן2|עוגןP}}{{כ}}P
 
|
 
|
 
|
 
|
 
|[[Antiparasitic products, insecticides and repellents]] ‏
 
|-
 
|{{עוגן2|עוגןR}}{{כ}}R
 
|
 
|
 
|
 
|
 
|[[Respiratory system]] ‏
 
|-
 
|{{עוגן2|עוגןS}}{{כ}}S
 
|
 
|
 
|
 
|
 
|[[Sensory organs]] ‏
 
|-
 
|{{עוגן2|עוגןV}}{{כ}}V
 
|
 
|
 
|
 
|
 
|[[Various‏]]
 
|}
 
 
 
==ביבליוגרפיה==
 
 
 
* [http://www.whocc.no/atc_ddd_index/ ATC/DDD Index 2013]
 
 
 
[[קטגוריה:Anatomical Therapeutic Chemical (ATC) classification]]
 

גרסה אחרונה מ־17:45, 23 באוגוסט 2021